Search Conferences and Exhibitions

Advances in Chronic Pain Management brings together leading experts in the fi  elds of pain, anaesthesia and neurology to discuss the central issues and current challenges involved in the management of patients with
chronic pain.

It is anticipated that participants will benefit from:

An understanding of the neurological basis of pain and how pain can be imaged in the brain Analysis of the psychosocial aspects of chronic pain and cognitive behavioural treatments
Insights into the optimal approaches for managing patients with fi  bromyalgia, neuropathic pain, trigeminal neuralgia, cancer-related pain and chronic pain following spinal cord injury
Updates on the advances in treatment for chronic pain including pharmacotherapies, radiofrequency
interventions, TENS and neuromodulatory techniques
Panel discussion about the impact of the NICE guidelines for lower back pain interventions
An opportunity to share and exchange ideas with leading practitioners in the fileld

The respiratory disorder market is highly competitive and brings in high revenues. The principal drivers are the increase in disease prevalence and the high economic cost of these diseases. With an increasing patient population and high-profile disorders, this market will continue to grow in the foreseeable future.

Happy to bring you its inaugural Respiratory Disorders Conference, which will feature keynote addresses, presentations, case studies and insights from outstanding speakers in this key area. This fundamental meeting will showcase the recent scientific developments and significant advances made in the COPD, Asthma, Pulmonary, Lung cancer treatments.

After the success of 2009`s conference, SMi is proud to present their 6th Annual Imaging in Oncology.

Taking place in London, UK, this conference will focus on a wide range of imaging techniques in a wide range of settings - from the preclinical, to the clinical, to the future of oncological imaging.  You will hear presentations from the leading experts in their fields on the latest developments in MRI, PET, SPECT, IR, Raman Sepctroscopy and more.

The changes RECIST 1.1 has made - an assessment one year on.  How is MRI being used to guide biopsies?  Can less harmful techniques than PET be as effective in imaging a tumour?  Are nanoparticles the future for advanced cancer imaging?  Looking beyond tumour size - what techniques can help us understand the internal workings of a tumour?  How can we reduce the harmful effects of imaging?  How effective is proteomic profiling using mass spectrometry in diagnostics?

Attend this event to discover the power of imaging for developing new drugs, following the reaction to therapies and developing a personalised approach to the treatment of cancer.

WHY SHOULD YOU ATTEND?

• Gain a refresher/update on the technical aspects specific to the regulation of rDNA derived medicinal products
• Improve your knowledge of the differences between the regulation of rDNA products and conventional small molecule drugs
• Compare experiences with delegates from across Europe

* Please note – the seminar assumes a scientific background and a basic knowledge of drug regulatory affairs

WHO SHOULD ATTEND?

• Life scientists moving into biotech regulatory affairs
• Technical and scientific decision makers in biotech start up operations
• Those with a life science background in the financial sector involved in due diligence or regulatory portfolio
• Those from small molecule backgrounds transferring to biotech product regulatory affairs

Postponed, delayed, curtailed, or outright canceled — you heard these words too often in the past 18 months. But as the global economy recovers, your company wants to come out of the starting gate fast with new applications and new market initiatives. Is your firm’s infrastructure ready to answer the call? Will you need to refresh network, server, or storage gear to meet the demand? Should you consider cloud or other strategic outsourcing alternatives? Do you have the skills you need to leverage new virtualization and automation tools? Can you finally fulfill that long-held dream of transforming the infrastructure and operations (I&O) function from an organization based on technology silos to a true service delivery team? These are the tough questions you need to prepare for as 2010 arrives.

This year’s I&O Forum will focus on the enormous tasks of planning, prioritizing, justifying, and carefully executing the wide range of people, process, and technology projects needed to get your firm “back in the black.” Specifically, the Forum will answer questions such as:

• How will I&O drive a fast recovery for firms by planning and prioritizing infrastructure initiatives that best align with business goals?
• How will I&O teams adapt and apply the recessionary behaviors of business case justification and financial acumen and tune them to the new norm for communicating with business leaders?
• How will I&O assess the post-recession readiness of its infrastructure to meet current and future business needs?

COPD: from evidence topractice will bring together leading experts in the field of respiratory medicine to discuss the current issues, latest developments and practical management of COPD.

It is anticipated that participants will benefit from:

• Comprehensive reviews of the fundamentals of COPD including an update on epidemiology, pathophysiology and co-morbid conditions
• An in depth focus on the management of stable disease including the importance of pharmacotherapy, pulmonary rehabilitation and home oxygen therapy
• A greater understanding of the management of acute exacerbations including the prevention of hospitalisation, the outcome of mechanical ventilation and the ethical issues surrounding resuscitation
• An overview of current models of care for COPD
• An insight into alternative therapeutic interventions including bronchoscopic and surgical interventions
• An opportunity to share and exchange ideas with leading practitioners in the field

The healthcare industry is coming under ever increasing scrutiny from regulators, both in the US and Europe, and the level of penalties are severe. In September 2009, Pfizer paid $1.3 billion, the largest criminal fine ever imposed in the United States, for the off-label marketing of Bextra and three other drugs. Pfizer paid an additional $1 billion in civil penalties resulting from the same illegal activities.

Whilst anti-corruption compliance is an issue for all major industry sectors, Pharma, Biotech and Medical Device companies are finding themselves particularly vulnerable when specific practices and industry customs are placed under the microscope. In the last 6 years, U.S. prosecutors have brought more than a dozen cases against drug makers for off-label marketing alone and won more than $6 billion in criminal and civil settlements. Estimates indicate that there are currently more investigations underway by the SEC and DOJ combined against medical device manufacturers than any other industry.

Reasons to Attend this Industry Leading Event:

• The leading experts from Switzerland, Luxembourg, France, Belgium, Germany, USA and UK
• High profile panel discussions: Including Conducting on-going Risk Assessment and Maintaining an Effective Compliance Programme
• Unique perspectives: hear from the former US Attorney General’s National Chair of the advisory committee on health care fraud
• Hear what whistleblowers are looking out for: from the Counsel in the Zyvox case
• Case Studies: BAE Systems - The Inside Track – what can the healthcare industry learn?
• Cross-border Investigations: The Trend of Increased Regulator Cooperation
• Hot Topics: Including Medical Devices, Off-label Promotions and Clinical Trials
• Unique Networking Opportunities: Join your peers in London to discuss the latest in best practice

The importance of developing effective pharmacovigilance systems has been fuelled by an increased focus on drug safety and the ever-changing regulatory environment. SMi’s inaugural Pharmacovigilance conference will explore key issues such as inspections, risk management, the use of Independent Data Monitoring Committees and establishing relationships with regulatory bodies. Attend and gain insights that will enhance your management skills and facilitate a more successful drug development strategy.

CNS is one of the largest and fastest growing therapeutic areas of the
pharmaceutical market. The ageing of the baby-boom generation combined
with new and emerging treatments for neurodegenerative disorders, including multiple sclerosis, Alzheimer’s disease and Parkinson’s disease, will lead to further expansion of the neurodegenerative therapies market.

CNS Clinical Trials conference you will examine the strategies offering
the greatest potential for success in CNS drug development, and understand the specifi c
challenges currently faced by developers in this market. In order to enhance productivity
in this fi eld, there has been an increased awareness of the need to align clinical and
preclinical research to facilitate rapid development of new CNS drug therapies. Medical
imaging is increasingly being used as a surrogate endpoint or biomarker of drug effi cacy
in all phases of CNS trials, enabling CNS developers to make more timely decisions.

SMi`s 3rd annual Unconventional Gas conference will be taking a practical look at unconventional gas production challenges, where the pressure is on to reduce costs and still deliver positive results.

To make the most from the underlying commercial opportunities, companies must be agile in analysing their business needs and implement robust strategies to maximise the benefit from these resources. At the same time technologies and the supporting infrastructure have to be both efficient and economically viable to ensure success.

Europe’s leading Unconventional Gas conference brings together industry experts and project operators to discuss the drivers, constraints and opportunities for non-conventional operations. Strategic examples and practical case studies will provide you with the know-how to succeed by being able to identify potential pitfalls and coming up with suitable solutions.

Accounting scandals and corporate governance shortfalls have led to new laws across Europe requiring greater transparency and heightened shareholder protections. At the same time, legal systems have been reformed to give shareholders unprecedented access to the courts. Such developments expose directors to greater liability, and lawsuits naming companies and their directors have consequently increased throughout Europe. Some recent suits have been settled for hundreds of millions of Pounds.

With more and more suits being brought, underwriters clearly need to be concerned about their exposure to claims, but the threat of regulatory investigations and shareholder suits is also creating unprecedented demand for D&O insurance. Significant growth in D&O premium volumes is now expected in the coming years, driven by both rate increases and new companies seeking to purchase D&O insurance.

Attend D&O 2010 in order to hear from the leaders and experts in the field of D&O liability insurance on:

• Where the claims are coming from and who they are being brought by
• The latest D&O policy structures, product innovations and terms and conditions
• POSI products: what is covered, what is excluded?
• The precarious position of the non-executive director
• Capacity, premiums and exclusions in FI renewals
• The liability of directors and officers on insolvency
• Potential D&O insurance opportunities in emerging markets

The recent ECDC/EMEA Technical Report - The bacterial challenge: time to react has highlighted the urgent need for development of new antimicrobial drugs.

"Industry`s pipeline contains very few new antibiotics active against multidrug-resistant bacteria. Without stimulating research and development into new antibiotics, an increasing number of infected patients will be without effective treatment". Bo Aronsson, EMEA.

"A future without effective antibiotics will exacerbate a situation where already at least 25,000 patients in the EU each year die from infections due to multidrug-resistant bacteria. Patients suffering from healthcare-associated infections will be particularly hard hit" Dominique Monnet, ECDC

SMi`s 12th Annual Conference will bring you up to date with new and emerging products in the antimicrobials market, with a particular focus on antibacterials and antifungals and allow you to learn from and network with some of the leading individuals and organisations in this ever important area.

Key topics include:

• A global update on emerging antibiotic resistant pathogens 
• Developments in the emerging global challenge of bacterial multi-drug resistance 
• Tackling resistance in gram-negative bacteria 
• Forming strategic alliances with large pharma to develop new antibacterials 
• New approaches to fungal and protozoal infections  
• Insights into novel therapies for overcoming resistance

If you file patents before the EPO and the USPTO you will know that the two offices have very different approaches to application requirements. 
 
This often results in having to draft TWO separate specifications for ONE invention, which is time-consuming, complicated and expensive.

This seminar will show you how to draft and prosecute ONE patent applications which will comply with the differing requirements of BOTH the EPC and the USPTO.

There will be practical worked examples, illustrations, demonstrations of ‘best practice’ and plenty of discussion, ensuring that you will go home with a realistic and workable solution to a perennial problem.

Pharmacovigilance is becoming ever more critical for pharmaceutical companies as the public and legislative pressure to ensure drug safety increases every day. Effective implementation of pharmacovigilance can aid drug development, benefit rational communication and sound public understanding, taking emerging regulatory policies worldwide into account. The challenge to manage adverse events in an optimal and efficient way and, at the same time, adhere to regulatory requirements will demand a great emphasis on pharmacovigilance in the near future.

5th Annual Pharmacovigilance conference will underpin processes and developments on many different elements including the regulatory and legislative framework, risk management, PSUR, live licensing, in drug safety and surveillance. With succinct themes, interactive sessions by key opinion leaders, our conference will bring latest insights, integrated strategies and best practices in pharmacovigilance.

The 5th Annual Oxford RNAi Conference, RNAi2010, will address most aspects of biology and application of RNA interference, and welcomes proposals on endogenous and exogenous roles of small RNAs in gene regulation, health and disease. We also invite proposals addressing technical advances in siRNA selection, chemical manipulations, delivery and bioinformatics tools.

The 3rd Public Sector Transformation Summit 2010 will build on that success and will again provide a definitive insight into the very best transformational success stories that have been undertaken across the public sector.

Following detailed research, the theme for the 2010 event will be on transformation success stories.  This means that you, and your Public Sector colleagues, will attend the event and learn directly from the individuals that have tackled subject areas, projects, programmes and initiatives and have produced distinguished results. 

After a morning plenary session the event will split into 3 streams, which have been highlighted during research as the core areas for transformation:

This one day meeting is designed to be an introduction to the topic of the electronic Common Technical Document (eCTD). 

The day is a mix of presentations on the subject, including detail about the specification itself and practical considerations for implementing the eCTD in your organisation. 

Topics to be covered include:-

• Introduction and overview of the eCTD
• What are the main components of the eCTD
• The ICH and European eCTD specifications
• Transitioning from paper submissions to the eCTD
• Considerations when selecting tools for the eCTD
• Process changes for the eCTD
• Practical experiences of submitting eCTDs

This course has been designed for persons with at least 2 years worth of knowledge in Drug Safety. The course will provide a very comprehensive and yet practical assessment of the main Regulations required to produce a compliant reporting Company.

This course would be of maximum benefit to those safety professionals who are working both in the Clinical and Post-Marketing Safety arena. The course covers very diverse activities within the Safety Department and would be advantageous to those who have either multifunction responsibilities or Medical Directors who manage teams in the various disciplines.

Key Topics to be covered:

• Due Diligence
• Training for Drug Safety - Reporting Duties
• Audits and Expectations
• Compliance and Drug Safety
• Independent Data Monitoring Boards
• Product Safety Reviews – Purpose and Function
• Safety Reporting in Licensing Agreements
• Developing Company Core Safety Information – CIOMS III
• PSURs
• The EU Clinical Trial Directive
• Risk/Benefit Determinations
• CIOMS V
• Crisis Management

Register for this one day conference to:

• Find out how the European Courts are handling pharmaceutical claims that are too broad
• Gain an update on EPO pharmaceutical and biotech case law
• Understand the legal implications of the Pharmaceutical Inquiry
• Improve your SPC knowledge and analyse recent developments
• Hear about the recent decisions in the US pharmaceutical sector
• Discuss employee compensation

Regulation remains very much at the forefront of the rapidly evolving telecoms market.  In order to remain competitive and responsive a thorough understanding of the regulatory landscape is essential. 

This event will bring mobile and fixed operators together with regulators and regulatory experts to debate the latest developments, determine strategies for compliance and uncover what is likely to happen next. 

Keynote Presentations By:

* Dr Bernd Langeheine
  Director for Electronic Communications Policy
  Information Society & Media Directorate
  General, European Commission

* Roberto Viola
  Secretary General, AGCOM 
  & Chairman, Radio Spectrum Policy Group


Key Issues To Be Addressed Include:

• The new regulatory framework – what’s the latest and how should operators respond?
• Article 7 and community consultation procedures
• The role of the new regulators’ group BEREC
• Pricing regimes in bundled environments
• Spectrum policy, ‘refarming’ and spectrum allocation
• Wireless broadband access
• Ensuring maximum benefit from the digital dividend
• Next Generation Access: investment and regulation
• Regulatory and competitive challenges of NGNs and NGA
• Funding models of Next Generation competitive broadband
• Providing a balanced regulatory environment for Mobile Termination Rates (MTRs)
• Call termination and interconnection in an IP world
• The latest developments in competition law

With the amalgamation of two flagship conferences - Telecoms Fraud and Telecoms Revenue Management - into one multi-streamed summit, this event will offer you an optimal learning and networking opportunity.
The event will scrutinise the latest developments and challenges in the fraud and revenue management areas and will offer you the chance to hear a number of exclusive operator case studies as well as meet leading industry experts from around the world.

Key topics that will be addressed on the agenda include:

• Determining how to identify and overcome traditional and Next Generation fraud challenges
• Developing an effective Revenue Assurance and Revenue Management strategy for new services and products
• Establishing how to evolve the Fraud Management System in order to develop an effective fraud control strategy for new services
• Understanding how to establish effective revenue leakage recovery strategies for different revenue streams
• Examining how to combat hacking at the traditional as well as IP PBX level
• Determining how to ensure an inherent Revenue Assurance culture across the entire business
• Understanding how to detect and prevent interconnection fraud
• Examining Revenue Assurance techniques for Fraud Detection, viruses and Malware

Time to sit back and relax?

No! If you don’t want to see those figures creep back up again you need to sit down and take a long hard look at what the industry is doing right and make sure it continues.

On the other hand, if you take another look at the figures above, there are two different messages you may not have seen:

Clearly there are still plenty of things going wrong, do you know exactly what all of them are? And could you honestly say that you have all the solutions?

Upstream Safety 2010 returns this year to help you do all of the above. Whether your focus is on behavioural safety, process safety or an amalgamation of the two, there will be a stream to fit your needs. And what’s more, following the feedback of last year’s attendees we will be capitalising on the interactive aspects of the meeting.

According to research with operators across the North Sea benchmarking is one of the most effective tools in the fight to make the offshore environment a safer place to work.

Businesses need clear direction and useful strategies that can help them overcome the unique challenges of LNG and maximise benefit from it, in these challenging times. They need the supporting investments, technology and ultimately ideas for a successful and prosperous trade.

SMi`s LNG 2010 will bring together leading oil and gas companies, financiers and expert consultants from around the globe to discuss issues that are most relevant to the LNG industry today. The two day programme will explore the major projects in Europe, Australia, Asia and Africa covering the most imminent commercial, financial and technical aspects of LNG production and trade in a distressed environment. After attending this event, you will walk away with innovative business techniques that will help you ride out of the economic downturn and not just survive, but successfully thrive in this highly competitive market.

This seminar has been specifically designed for those needing to improve their knowledge of the legal and regulatory framework that surrounds pharmaceutical patents in the US.  Two US Patent Attorneys (both with extensive knowledge of how European firms operate) will guide you through the day, including:

• Strategies for protecting your pharmaceutical inventions
• The complexities of listing a patent in the FDA Orange Book
• US claim strategies and US and Drug administration procedures
• US patent litigation
• An update on the ongoing debate on follow-on biologics in the US Congress

Who Should Attend?

• Patent Attorneys
• IP Managers
• Lawyers

• OFAC’s compliance expectations for US and non-US entities
• Working effectively with HM Treasury on obtaining licenses
• Designing effective systems and controls to prevent sanctions breaches
• Promoting economic sanctions awareness
• Preparing for greater enforcement of EU blocking measures

Widening OFAC Investigations of European Entities Continue to Make Headlines.

Is Your Company or Client Next?

Now more than ever, economic sanctions pose unprecedented compliance risks for financial institutions, insurers and exporters in Europe.

The US Treasury Department’s Office of Foreign Assets Control (OFAC) has stepped up its international enforcement efforts and is committed to ensuring all global companies carefully comply with US sanctions regulations no matter where located. The £231 million Lloyds TSB penalty, the largest fine ever imposed for violations of US sanctions regulations, ANZ Bank’s recent $5.75 million settlement as well as other investigations into the shipping industry, continue to serve as a harsh reminder of the magnitude of consequences for entities that violate US sanctions laws.

While ongoing OFAC investigations continue to grab headlines, European and foreign entities must also be ever mindful of UK and EU sanctions developments. The Financial Services Authority recently released a report on economic sanctions compliance to encourage all firms, large and small, to enhance compliance processes. Moreover, cooperation between US and European sanctions authorities is increasing and EU Member States are taking steps to tighten and enforce sanctions regulations.

Under this increased climate of risk, global companies and financial institutions operating in Europe must institute preventative measures and enhance existing compliance programmes. Failure to detect and prevent sanctions breaches is otherwise likely to result in staggering penalties and reputational damage.

Following the success of their Economic Sanctions conferences in London, Frankfurt and Washington, DC, American Conference Institute and C5 Group are pleased to introduce the 3rd European Forum on Economic Sanctions. Senior government officials, industry leaders and attorneys will once again provide insights on critical sanctions issues, including:

• OFAC’s compliance expectations for US and non-US entities
• Working effectively with HM Treasury on obtaining licenses
• Designing effective systems and controls to prevent sanctions breaches
• Promoting economic sanctions awareness
• Preparing for greater enforcement of EU blocking measures

Improving the Reliability of patient observations and benchmarking practice to ensure the safety of acutely ill patients on the wards

This one day conference will include a series of presentations providing a practical guide to recognising and responding to the deteriorating patient improving the reliability of patient observations and benchmarking practice to ensure the safety of acutely ill patients on the wards.

Patient recruitment and retention are critical to drug development programs. Patient recruitment if not adequately planned for can extend development time-lines by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for analysis and subsequent filings.  

Key topic include:

To fulfil the intense need for specialised updates in the world of performance management, the 10th Annual Performance Management for Police event will once again provide the UK police service, and those countries with similar challenges, with a forum to discuss and dissect the very latest performance guidelines, targets, initiatives and strategies to combat a lack of resources and become as high-performing as possible.

Designed for both the strategic view and the tactical approach, each year Police Forces and Authorities descend on London to networking and set their plans for the future performance management programmes. To quote one of 2009’s attendees, the annual conference is:

Driving & Capitalising on a 360° View of the Customer: Knowledge – Service – Performance – Profit

Tailored for those driving strategic growth across regional and global contact centres, the unique Exchange format provides Contact Centre, Customer Service, Customer Experience, CRM & Customer Strategy Executives with the, the opportunity to tackle key challenges in an open and frank discussion forum.

Why attend the Executive Customer Contact Exchange?

Through carefully selected keynote addresses, structured networking activities, intimate boardroom style discussions and one-to-one meetings with leading solution providers, find out how to:

• Design and deliver the right multi-channel contact strategy that meets your customers’ needs
• Streamline, consolidate and integrate operating processes without impacting your customers’ experience
• Ensure your outsourcer delivers the service your customers expect and the one your brand promises
• Maximise performance and profit from your people by empowering your workforce to drive change from the bottom-up
• Propel customer satisfaction scores to new heights by creating a customer obsessed culture
• Extract maximum value from the latest contact centre solutions including social media, mobile CRM, cloud computing, Web 3.0 and unified communications

The Oil & Gas sector works in some of the harshest environments on earth – remote from infrastructure, in extreme temperatures and weather conditions.  Secure communications, not just voice communications but also for the transfer of well and drilling information are vital.  SMi’s 3rd annual Oil & Gas Satellite Communications conference will address the various opportunities and challenges in this field.

Child and adolescent addictions will bring together leading experts in the fields of psychiatry, psychology and psychotherapy to discuss the current issues, latest developments and practical management of child and adolescent substance misuse.

It is anticipated that participants will benefit from:

• A comprehensive overview of the trends in adolescent substance misuse and addiction
• A greater understanding of the clinical consequences of substance misuse
• A review of the latest pharmacological and psychological treatment interventions
• A raised awareness of the current issues in child and adolescent addiction services and policies
• An opportunity to share and exchange ideas with leading practitioners in the field

Two days of training which can be booked individually or together. Discount available if booked with REGULATORY AFFAIRS FOR SUPPORT STAFF ~ PART 2 on 26th March 2010

Topics to be covered:

• Learn about the Drug Development Process – from Drug Discovery to Product Launch and Beyond
• Understand the background of European Law – Regulations, Directives, etc.
• Discover where you can find information on Regulatory Affairs, Approvals, Withdrawals, etc.
• What is the Centralised Procedure?
• Understand the EU Clinical Trial Directive
• How to Seek Scientific Advice in Europe
• What is the Common Technical Document

Part of the 2010 Mental Health Conference Series

Chaired by Ian McPherson Director National Mental Health Development Unit this one day conference provides a practical guide to delivering Quality, Innovation, Productivity and Prevention in Mental Health. Jim Easton National Director for Improvement and Efficiency NHS Quality, Innovation, Productivity and Prevention (QIPP) opens the day with a focus on developments from the NHS Productivity Unit and the individuals role in supporting quality, innovation, productivity and prevention.

Two days of training which can be booked individually or together. Discount available if booked with REGULATORY AFFAIRS FOR SUPPORT STAFF ~ PART 1 on 25th March 2010

Topics to be covered:

• How to apply for a Marketing Authorisation in the EU
• Key Aspects of Safety Reporting
• Pharmacovigilance and GCP Inspections
• Managing Product Labelling
• Discuss Licence Variations
• Understand Parallel Imports & Generic Applications
• Managing a Regulatory Affairs Department

The conference (eligible for CPD accreditation) combines presentations, workshops and discussions around the theme of:

`Beyond Words: Trauma and the Human Condition`

Trauma impacts on individuals, families and societies in ways that challenge the human capacity to endure, survive and grow. This conference provides an opportunity to learn how psychotherapy, of various theoretical orientations, endeavours to transform the unspeakable and bear the intolerable, often challenging psychotherapists to go beyond the technicalities of words, of therapeutic techniques, in the search for understanding and enabling of individual growth and recovery. Our keynote speakers and presenters have demonstrated this in their search to improve psychotherapeutic theory and practice and their work sets the context for this conference.

Day 1 - Integrating mind and body in the psychotherapeutic endeavour

Day 2 - Human values, trauma and society- compassion, war and psychosis

Confirmed Keynote Speakers:

Dr Phil Mollon, Clinical Psychologist, Psychoanalyst and Energy Field Psychologist

Professor Paul Gilbert, Mental Health Research Unit, Kingsway Hospital Derby

Other confirmed speakers:

Following the hugely successful event in 2008, the 10th International Conference on Developments in Power System Protection will provide a leading forum for the international engineering community to meet and exchange ideas.

Through our tailored programme of presented papers, discussions and tutorials, attendees of this conference will gain an up-to-date understanding of recent developments and future trends in the design, application and management of power system protection and control systems.

These are all aimed at engineers involved in the application, ownership, management, design and development of power system protection and control systems. Paper submissions are invited from utilities, generation companies, industry, manufacturing and railway industries, as well as consultants and academia.

All papers will be peer reviewed and accepted papers will be delivered by oral presentations. The conference will be preceded by a one day tutorial covering topics of relevance to the subject area.

This event regularly attracts over 300 senior decision makers from global organisations, from senior directors or engineers to consultants and research students. The DPSP series continues to grow into one of the most important conferences in the power system protection and control systems area.

Regenerative medicine is set to revolutionise healthcare as stem cell, tissue engineering, gene therapy and materials science come together to transform patient treatment. Bringing you the latest in translational applications from leading experts, don`t miss this exceptional showcase of medical innovations in this fast-moving field.

By attending this conference you will gain the latest insights into:
• The economic future of the global regenerative medicine market and acquiring venture capital
• The use of stem cell therapies in type 1 diabetes
• Small molecule drugs to stimulate neurogenesis and neuroprotection in Parkinson’s disease
• The use of direct stem cell therapies in cardiovascular diseases
• The use of direct stem cell therapies in wound healing
• The use of direct stem cell therapies in bone remodelling
• Gene therapy for retinal degeneration
• Scaling-up in the lab
• Scaling up in manufacturing
• Clinical trials for novel therapies
• How to commercialise your product
• Overcoming patent, legal and regulatory hurdles

Pharmaceutical packaging and labelling is considered an essential aspect of the product. The role of packaging and labelling has increased considerably and constantly advancing over the last few decades. This area has been experiencing emerging regulatory issues and stringent restraints.

Key Benefits:

• Stay up-to-date on the latest innovations in packaging and labelling
• Learn how can you turn a cost and hygiene factor into a commercial benefit?
• Examine new strategies in fighting counterfeiting
• Gain knowledge about legislation and existing models – EU, USA, Greece, Italy, Belgium, Turkey
• Find out about the supply chain security and compliance
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies

FinPlan`s multi-streamed agenda full of real-life case studies and a multitude of interactive debates addresses some of the crucial challenges and opportunities available for financial planners today. Over 100 Financial Planners attend from all over the UK to network with their peers.

With a carefully designed agenda tailored to address financial planners` most pressing concerns, FinPlan provides you and all other Financial Planners with the tools you need to develop your business, including practical tips on how to:

• grow a successful recurring revenue business and increase profitability
• build and maintain productive relationships with your clients
• agree the appropriate remuneration for your services
• grow your company`s brand through a winning marketing campaign
• maximise efficiency by developing credentials, qualifying clients and systematising your workflow
• build scalability in your fee-based business for effective succession planning
• adopt the investment management approach that delivers best returns
• select the right technology to help you grow your business
• improve service offering by incorporating wraps into your business

The energy industry, like any other has to be fully equipped to successfully overcome the legal impediments arising out of a volatile market.

SMi’s Legal Issues in Oil and Gas 2010 will bring together a collection of regulators, in-house counsel and private practice lawyers to provide comprehensive views and solutions needed to mitigate the legal risks surrounding the industry. Attendees will have the opportunity to hear discussions and network with our renowned international speakers.

Key topics to be addressed:

• Current legal issues in view of security of gas supply
• Mergers and acquisitions in a distressed market
• Resource nationalism: Latest developments, remedies and prevention
• Effectively identifying and mitigating risks when drafting energy contracts
• Legal issues in cross border oil and gas pipelines
• Legal issues in underground gas storage
• International obligations for decommissioning in oil and gas

• Cell line misidentification
• Recent advances in cell culture methods as alternatives to animal testing
• Metabolomic profiling of mammalian cell lines – New approaches for understanding recombinant antibody production
• Development of Technology for the Routine Growth of Cells in Three Dimensions
• Remote Monitoring of Cell Culture - Splitting cells based on fact rather than tradition
• Harvest your cells without trypsin! Introducing cell releasing UpCell surface by temperature control
• Embryonic stem cell bioprocessing
• Instant immortal cell cultures from Cdkn2a null mice: functional analysis of colour mutations using melanocyte lines
• Wnt signals in Prostate Cancer and Embryonal Carcinoma Cell Growth and Differentiation
• Developing in vitro 3d models of breast cancer

• Drive Integrated Luxury Marketing Through Leadership For Greater Results In the High Net Worth Market
• Gain Affluent Demographic & Behavioural Insights To Create Relevant Customer Communications
• Expand International Horizons To Diversify Your Customer Base And Grow Your Market Share
• Identify The ROI Of Luxury Online Brand Activities, Ensuring You Best Invest Your Limited Budget
• Improve The Online Luxury User Experience To Drive Customer Engagement, Keeping Your Brand Top Of Mind

The AAH Bookfair is an annual event that takes place during the annual AAH Conference. The Bookfair takes place over three days within the main conference venue. The Bookfair comprises many international publishers and magazines and attrracts upto 500 conference delegates. The Bookfair takes place at a different UK venue each year.

Medical devices manufacturers require a more rigorous and strategic approach to safeguard product prices and prevent competition. Innovative manufacturers that have integrated their pricing and product strategies will achieve exceptional growth and profitability in this changing environment.

Take advantage of the networking opportunities and gain insights on:
• Evaluation of reimbursement mechanisms in the five major EU markets (France, Italy, Spain, Germany and UK)
• Opportunities to obtain higher reimbursement for innovative medical devices
• NICE health technology and device appraisals: Processes and people
• Developing a reimbursement strategy for introducing an innovative medical device into a prospective payment based system (DRG)
• Combining reimbursement and clinical expertise to realise clinical utility targets
• Market Access and funding for medical devices in Central Eastern Europe
• Maximising the value of CED from a device manufacturer perspective
• Assigning monetary value to innovative medical devices and diagnostic technologies

The topics of interest include but not limited to

•   Formal Methods and Notations for representing requirements
•   Requirements analysis theories, concepts, methods and techniques, and their practical applications
•   Business process and workflow modeling, analysis, integration and management
•   Requirements quality and adherence to standards
•   Requirements Quantification
•   Methodologies for information systems design and implementation
•   Applications, case studies, and management issues
•   Model and meta-model transformations
•   Computational independent models
•   Platform independent models
•   Formalized business process, methodologies
•   Integration within development frameworks
•   Approaches, frameworks, methodologies and standards for requirements analysis
•   Methodologies for information systems design and implementation
•   Evaluation and selection of tools
•   Organisational semiotics

The 5th Annual MDM Summit Europe 2010 is Europe`s premier event dedicated specifically to MDM, CDI, PIM and Data Governance. In three extremely well-spent days, you will:

• Discover how to increase your company`s ability to accelerate its rebound out of the financial crisis
• Understand the key decisions and tasks required for you to get started with one or more of these scenarios in your own organisation - customer data integration (CDI), product information management (PIM), or data governance
• Recognise what is driving business interest in MDM, CDI, PIM, and Data Governance solutions
• Establish what are the better architectures and vendors ... and how these solutions differ from data warehouse and CRM initiatives
• Learn how the market and key technologies evolve ... and who the leading vendors will be
• Confirm how an IT organisation gets started ... and how IT sells MDM to the business
• Create an action plan to establish a Data Governance programme
• Determine the most successful best practices for creating a "single customer view"... and how to decide to build, buy, or extend an MDM solution
• Add 250+ MDM experts to your professional social network and increase your personal net worth to your enterprise

Theme A – More/All Electric Transport

1. Railway Systems
2. Marine Propulsion, Drives and Power Systems
3. More-Electric Aircraft Technologies
4. Actuation Systems
5. Starter/Generator Systems
6. Electric/ Fuel Cell/ Hybrid Vehicles
7. Automotive Systems
8. System Control

Theme B – Generation, Transmission and Distribution

1. Converters for Grid Connection
2. FACTS, Grids and Micro-Grids
3. Superconducting Components and Systems
4. Embedded Generation
5. Synchronous Machines and Special Generators
6. Power Quality and Protection
7. HVDC
8. Energy Efficiency and Demand Side Control

Theme C – Machines and Drives

1. Integrated Drives and Applications
2. Energy Efficient Drives
3. Fault Tolerant Drives
4. Motion Control Systems
5. Advanced and Sensorless Machine Control
6. Induction, Permanent-Magnet and Reluctance Machines
7. Special Machines
8. Actuators and Linear Machines
9. Condition Monitoring
10. Design and Modelling

Theme D – Power Electronics

1. Switch-Mode Power Supplies
2. Resonant Converters
3. Power Factor Correction/ Active Filters
4. Converters for Special Applications
5. Matrix and Multi-Level Converters
6. EMC and Power Quality
7. Thermal Management
8. Power Semiconductor Devices, Packaging and Materials
9. Power Converter Control
10. Capacitors, Inductors, Transformers and other Components

Theme E – Renewable Energy Systems

These two trade only events are taking place at the same time at Westpoint Exeter.

The Taste of the West Trade Show in 2009 saw an increase in buyer numbers of 30% from 2008.

The SOURCE Exhibition is new for 2010 and is being held to complement the Taste of the West Trade Show , and provide the perfect professional platform in the South West for food and drink producers, and service providers.

Between the SOURCE Exhibition and the Taste of the West Trade Show, buyers will have the opportunity to see, smell and sample a wide selection of the region’s finest produce, alongside a selection of UK and International food and drink suppliers. There will also be companies showing a range of services such as packaging, labelling, refrigeration, EPOS, shopfitting, design, accountancy, recruitment and training.

The current economic crisis and resulting unavailability of credit is pushing Mobile Operators to radically reduce CAPEX and OPEX. Drawing on business models from alternative industries ,such as aviation and transport, many of the large Operator groups are developing innovative business partnerships to reduce CAPEX and move to fixed Opex-led models.

• Are you currently involved in projects to bring down the cost of your network expenditure?
• Do you want to learn how the major Operator groups are developing internal offshoring initiatives to reduce costs?
• Do you want to hear how Mobile Operators have reduced their Network related spends by up to 25% through network sharing?
• Do you understand how to maximise cost-saving through managed services by outsourcing both the core and access network planning, operations and maintenance?
• Do you want to hear how the financial community can fund your network build?

If you have answered yes to any of the above, then make space in your diary for this key industry event.

This senior-level strategy forum will have CxO and Director level speakers from the major worldwide mobile operators.

Rising energy demand and concerns over security of energy supply are the driving force behind the increasing interest in coal gasification.  SMi’s 3rd annual Gasification conference will bring together leading industry experts to share information and discuss the challenges facing the industry.

Covering a wide range of industry driven topics such as the latest UCG and IGCC developments, Gasification 2010 will also be uncovering some newer trends including biomass gasification and niche technologies within the field. Featuring speakers from key projects around the world and providing in-depth analysis of the issues facing the sector, this comprehensive conference provides essential information for the coal and power industries.

Key topics to be addressed:

The healthcare industry is coming under ever increasing scrutiny from regulators, both in the US and Europe, and the level of penalties are severe. In September 2009, Pfizer paid $1.3 billion, the largest criminal fine ever imposed in the United States, for the off-label marketing of Bextra and three other drugs. Pfizer paid an additional $1 billion in civil penalties resulting from the same illegal activities.

Whilst anti-corruption compliance is an issue for all major industry sectors, Pharma, Biotech and Medical Device companies are finding themselves particularly vulnerable when specific practices and industry customs are placed under the microscope. In the last 6 years, U.S. prosecutors have brought more than a dozen cases against drug makers for off-label marketing alone and won more than $6 billion in criminal and civil settlements. Estimates indicate that there are currently more investigations underway by the SEC and DOJ combined against medical device manufacturers than any other industry

As companies focus on steering themselves out of the economic downturn, they can ill afford a bribery and corruption probe as well. Reviewing and revising an effective corporate anti-corruption compliance policy will demonstrate to employees and, if necessary, regulators, that your company considers anti-corruption compliance to be an important corporate goal. If undertaken properly, anti-corruption compliance can be a valuable corporate asset that enhances company operations, facilitates compliance with law and mitigates damage when and if violations occur.

Don’t allow what has happened to other companies happen to your organisation.

With increased international co-operation, the potential for investigations is growing by the day. It has never been more important for the healthcare industry to benchmark their compliance programmes, compare operating practices and review internal anti-corruption procedures.

Hear from top industry experts and their advisors, including representatives from:

• Leading pharmaceutical, life sciences and medical device companies
• Key regulatory bodies
• Top international law firms

The US Withholding Tax QI Regulations as you know them are changing almost beyond recognition. These changes remain fluid, and it would take a brave person to state with any confidence how the regulations will look when they are finally made law. This has resulted in a  great deal of confusion within individual firms – both QIs and NQIs, and including stockbrokers, private wealth managers, institutional fund mangers and custodians – as to the best response.

To this end, Osney Media’s Withholding Tax on US-sourced Income event on 20^th and 21^st April will provide a timely opportunity for all those affected by these sea-changes to benchmark with peers, and hear the thoughts of many of the global thought leaders in the field. It will be the best opportunity for the market to convene and find out just what is going on, what has changed, and how this will affect your individual roles and your company’s position. Planning ahead has never been more important.

Over 120 people attended the previous event on October 2009, and the impact of US government bills HR3933 and HR4213 (and any other relevant bills) means this event will be just as popular. The landscape has changed dramatically even since October, and you cannot afford to miss this opportunity, whether your focus is strategic, operational or legal. We look forward to helping you come to terms with the potential impacts – whatever they may be come April 2010!

Definitive cures for asthma and COPD remain elusive but products developed to treat the symptoms provide one of the highest sources of revenue for the pharmaceutical industry. SMi’s sixth annual Asthma & COPD conference will present attendees with an exceptional line-up of speakers and an unrivalled forum for discussion and debate.

There will be an opportunity to hear about new research involving the use of bronchodilators and kinase-inhibitors as well as antibody based biologics. Presentations will also cover topics such as new therapeutic targets in asthma and COPD and optimising respiratory clinical trial data.

• Hear about novel endpoints in COPD clinical trials
• Explore the application of in vitro cell models in drug development
• Learn about the use of the use of protein kinases as drug targets
• Discuss methods for candidate drug selection and risk management
• Network with industry associates and share experiences

Having run highly successful CSV conferences in the past, in 2010 SMi are revisiting the issue of Computer Systems Validation in the Pharmaceutical Industry to look at whether the pharmaceutical industry could change its attitude towards CSV, so that it is done sensible, effectively and practically.

Taking place in London, UK, this conference will focus on a wide range of issues withing the CSV arena, including the regulatory aspects to CSV - whether the current guidelines need expanding, reinterpreting or rewriting - CSV in an R&D context, the need for a risk-based approach to CSV, the respective benefits of doing CSV in-house or contracting it out, and developing a `bigger picture` approach to CSV.

Questions examined during the conference will include: what is the role of QA departments?  How much CSV is enough?  Does CSV hamper clinical R&D?  Should all CSV be risk-based in analysis?  Should the industry use a consortium approach to vendor-CSV audit?  Are consultants too widely used - would CSV be done better in-house?  What are the CSV implications for mergers?  How to develop a quality model?

Attend this event to discover how computer systems validation does not have to be difficult, time-consuming and costly, and to learn how to plan for better implementation of a CSV programme.

This seminar will focus on the following:

• ISPE Good Engineering Practice Guide
• Applicable Regulations
• Risk Management
• Practical application of science and risk based approach to process and system equipment verification
• Making best use of supplier documentation
• Understanding of terminology and the ‘busting’ of some myths
• Practical approach to documentation and document approvals
• Change management and how to gain acceptance of this
• Auditing
• Maintenance management
• Opportunity to take part in group exercises to use tools in real life examples

At the end of this seminar, participants will be able to:

• Balance expenditure and activity in relation to cost and benefits
• State a clear definition of good engineering practice
• Understand how the risk based approach will improve effectiveness and reduce costs
• Have a common understanding of the concept and principles of GEP
• Explain how GEP concepts may be applied in the healthcare industry
• Balance expenditure and activity against the associated risks and benefits of a defined scope of work

The event is designed for those who are concerned with produced water treatment, management and handling. Regulators, offshore operators, service companies, technology and equipment suppliers as well as consultancy and R&D organisations are all welcome to submit papers.

Topics - As a guide, papers are invited from the following areas: 

• Legislation update
• OPPC Regulation implementation and results
• Integrated water management
• New and emerging surface treatment technologies
• Volume reduction technologies and economics (water shut-off, downhole, subsea separation, and produced water re-injection)
• Produced water compositions and characteristics
• Risk based approach, options/benefits
• Environment monitoring
• Field operational experiences
• Production chemicals and their effect on produced water treatment

Join industry colleagues and international military representatives at SMi`s Combat Service Support Operations conference.

Hear the latest national strategies and programmes supporting personnel and equipment on deployed operations world-wide. Assess technology and current industry capabilities. Explore the lessons learned from operations in Iraq and Afghanistan and additional presentations focused on supporting NATO, ISAF and United Nations deployed operations. Additionally, hear from and network with key international policy and decision makers who will provide you with a unique insight into supporting current and future combat operations.

Combat Service Support Operations is designed to address the ever changing operational needs, technological aspects and challenges within the global support community.  This event brings together leading members of industry and senior military experts to discuss, develop and compare global service support strategies.

On behalf of the local Organising Committee, I would like to invite you to come to Edinburgh for the British Geriatrics Society Spring Meeting on 22-24 April 2010.

Edinburgh is the capital of Scotland and one of the most beautiful cities in the world, with its mediaeval Old Town and Georgian New Town designated a UNESCO World Heritage site and it was declared the first UNESCO City of Literature.

The conference will be held in the Edinburgh International Conference Centre, a state of the art building, and conference accommodation is booked nearby in the heart of the Old Town. Edinburgh is easy to reach by air, train or road.  The scientific programme covers a wide range of topics and choosing highlights is a matter of personal choice. On Friday afternoon we have a joint session with the British Association of Stroke Physicians with a series of presentations by leading figures in stroke medicine. Anyone interested in running a stroke service will not want to miss this. We also have a session devoted to geriatric medicine in developing countries and a Continence Masterclass. The Marjory Warren lecture is being given by Professor David Stott from Glasgow, a champion of clinical research in older people, especially in vascular disease and cognitive impairment. The external speaker is Professor Sir Neil Douglas, Professor of Sleep Medicine in Edinburgh and current Chair of the joint Royal Colleges who will be enlightening us on the subject of sleep in older people.

Delegates from low-middle income countries
As part of its international strategy encouraging overseas visitors to participate in our scientific meetings it has been decided to waive registration fees for presenters from low income or low-middle income countries .

An inspection conducted by the US FDA is a very important milestone in any pharmaceutical company`s lifecycle.  A successful inspection opens the door, or retains access to one of the world`s most lucrative markets.  When it is unsuccessful the inspection can seriously damage the reputation of individuals within the company and the company itself.  Penalties such as Warning Letters and Import Restrictions can easily be applied.  Further action such as severe fines and Consent decrees can follow; these measures can seriously affect the viability of the company.  FDA look for a culture of Quality that is led from the very top of the company.
 
The format of this course is a mix of classroom activity and practical workshops to prepare you for different types of FDA inspections and the challenges they present.  The course is directed toward personnel from, development, manufacture, quality and/or regulatory compliance who are responsible for FDA inspectable activity relating to the manufacture and quality control of pharmaceutical products for the USA market.
 
THIS COURSE WILL PROVIDE:

• Background to FDA`s Inspection authority
• The background to changing FDA approaches
• The knowledge to help you prepare to successfully host an FDA inspection
• Common FDA inspection target areas/systems
• Running an inspection ready room
• Help in interpreting what a Form 483 actually states and how to formulate your response

Cloud Computing is an increasingly heard buzzword in the telecoms industry these days and there seems to be substance behind the buzz. By moving into the Cloud Computing arena, and beyond their role as mere connectivity providers, operators will be able to position themselves within the value chain in a very prominent role.

IIR’s Telecoms Cloud Services Summit will examine how operators can leverage their core strengths and existing assets to develop and deliver competitive cloud-based services that will differentiate them from other Cloud companies and deliver true value to their customers. Operator case studies and expert presentation will address the internal technical and organisational prerequisites and potential external barriers to the successful deployment and adoption of cloud services. In addition, the event will explore the various cloud service models (SaaS, IaaS, PaaS) and service model combinations that are emerging and that will enable operators to create new and sustainable revenue streams. 

The Summit will feature practical operator case studies, expert presentations as well as interactive and informal discussion sessions that will enable delegates to find answers to their most pressing questions. The exhibition accompanying the Summit will give delegates the opportunity to network with industry experts and explore the latest Cloud Computing solutions.

A review of the EU Guidance on the SmPC considering important changes in the Guidance, as well as discussion on the Clinical, Pre-clinical and Pharmaceutical Issues in creating or amending the SmPC (with special emphasis on the anticipated problem areas)

The other important issue regarding the SmPC is EU harmonisation, and this meeting will consider procedures for harmonisation emphasising articles 29 and 30, and outline experience to date from both a regulatory and industry point of view.

TOPICS TO BE COVERED AT DURING THIS MEETING:

• EU SmPC: Significant and interesting changes in the Guidance
• Industry view of changes to the SmPC guidance
• EU Harmonisation of the SmPC: articles 29 and 30 harmonisation
• Industry view of harmonisation
• The SmPC and the Package Leaflet

10-Night Canary Islands Cruise Conference

The purpose of this CME activity is to introduce new clinical paradigms, novel early detection technologies, and sophisticated laboratory tests for the prevention and management of a wide range of important medical problems. Coronary disease, cancer, sleep apnea, hypertension, dementia, osteoporosis, erectile dysfunction, and diabetes are among the diseases considered with a view towards noninvasive diagnosis and cost effective preventive care.

Preliminary Objectives for Activity:
"At the conclusion of this CME activity, participants should be able to:"
--Incorporate broad-based preventive medicine principles from “A to Z” into an office practice
--Identify and appropriately treat blood cholesterol abnormalities to prevent CHD events in patients at intermediate to high risk for CHD
--Apply standard of care lifestyle and pharmacologic guidelines to treat individuals with blood pressure elevations
--Provide dementia-prevention guidelines and early treatment to patients in an office practice
--Deliver travel medicine advice to international travelers
--Diagnose and appropriately treat male patients with decreased bone density
--Comfortably diagnose and treat bipolar disease in a primary care setting
--Discuss the full spectrum of metabolic syndrome and why it is important for the primary care physician to maintain a high level of awareness
--Appreciate how to integrate the results of coronary calcification imaging into conventional risk factor assessment
--Review the roles and limitations of emerging imaging and physiologic tests in preventive cardiology
--Develop a practical understanding of the unique aspects of heart disease in women
--Consider sleep apnea in patients with hypertension, cardiovascular disease and diabetes and learn the value of recognition and treatment in younger individuals with non-classic signs
--Develop an appreciation of the roles and limitations of all colon cancer screening options and where CT colonography fits
--Individualize therapy based upon sophisticated lipoprotein analysis and new measures of inflammation

SMi`s industry-leading High Throughput Screening conference returns for its sixth year.  The theme of this year`s conference will be how to lead HTS down an intelligent route towards lead generation.

Taking place in London, UK, this conference will look at a wide range of issues within the HTS arena under several `topic umbrellas`.  The State of the Industry will look at the best of HTS now, outsourcing and hit-to-lead bottlenecks.  Focussing HTS will investigate methods to increase the quality of the leads generated.  There will be in-depth studies into In-Silico Screening and GPCRs, and finally, a look to the future in New Screening Technologies.

Questions examined during the conference will include: how successful is HTS now?  Is outsourcing worthwhile economically?  What are the IP issues?  Can intelligent research outperform HTS?  Does iterative screening hold the key to obtaining high quality leads?  How can we redesign the HTS framework?  Do we rely on established assays too much?  Can virtual screening ever replace HTS as the standard lead generator?  How can HTS be used successfully in harnessing the power of GPCRs?  What is the potential for biophysical tools to be used in screening?

Attend this event to discover how High Throughput Screening can be made more intelligent, more focussed and more beneficial in drug discovery

Immunogenicity is a significant area of discussion in the pharmaceutical and biotech industry with new strategies and practices being developed, also it is a primary safety concern for regulators.

Key Benefits:

• Examine the efficient methods of immunogenicity testing
• Assess immunogenicity risk assessment strategies
• Evaluate the impact of immunogenic responses on efficacy and safety
• Analyse the strategies for pre-clinical immunogenicity testing
• Discover how to address immunogenicity issues related to formulation
• Gain an insight into the impact of anti-drug IgE antibody testing
• Hear case study updates from top biopharmaceuticals on immunogenicity
• Understand immunogenicity from a practical physician`s perspective

IIR’s Mobile Network Performance 2010 is the key industry event for networking, learning and sharing information on the latest developments in network performance measurement and service quality management. Join us on the 26 – 28 April and benefit from the opportunity to benchmark your strategy.

The conference will feature a fully interactive programme, with key presentations and interactive sessions addressing a range of in-depth topics including:

• Using performance measurement to reduce operational costs

• Developing a customer-centric SQM framework

• Understanding how to measure the performance of you HSPA network

• Analysing the latest developments in LTE testing

• Monitoring mobile backhaul performance to maintain optimal end-to-end service quality

• Measuring the performance of UMTS deployed in the 900 MHz band

Leaning and Leading: Driving transformation in a recovering market for enhanced customer experience and rapid growth opportunities.

In an original format this European first PI Visionary Council provides reflection on the role of Process Excellence in transforming business and moving into the economic upturn

The changes, challenges and opportunities facing the world`s insurance and reinsurance markets are happening at lightening speed. Keeping up with the increasingly complex and contentious handling of reinsurance claims can be extremely demanding and time consuming. With new developments, year after year, everybody involved in reinsurance claims needs up to the minute guidance on handling, managing and resolving claims swiftly and effectively. Can your company afford to fall behind?
In these challenging times, C5 has specifically tailored Reinsurance Claims to provide you with the latest strategies for handling today’s complex reinsurance claims. An outstanding faculty of leaders from industry and the law has been assembled to give you a practical guide to:

• How to prepare yourself for the key reinsurance claims issues facing the market in 2010 and beyond
• The latest developments in Asbestos Claims in Europe, the UK,  the US and key emerging markets 
• Implications of the Damages (Asbestos-Related Conditions) (Scotland) Act 2009 for pleural plaques and related claims
• How evolving case law such as Wasa v Lexington or Equitas v R&Q will impact claims handling behavior
• The changing legal landscape for Class Action in Europe: how close are we to US style class action in Europe and what are the implications for the reinsurance industry?
• Personal injury claims: how to adjust to the upward trend for increasing claims cost in Continental Europe, including an update on Eastern Europe
• Long term claim payments for personal injury and periodic payment orders in the UK: how to determine today how someone will receive for the rest of his life?
• Correctly determine your exposure:  An update on the interpretation of  the key clauses of the Reinsurance Contract in the US, UK and Europe
• The likely impact of Lloyds’ new claims transformation process upon the lead and the following market

If you want to safeguard against potential losses and maximise your profits you need to make sure you attend this conference no matter what it takes! You will thank yourself later!

Capturing, retaining, and transferring your company’s most valuable asset

Why Attend:

The need for cost effective information management and integration is more critical than ever. The projected retirement of key workers, coupled with the current economic climate means that information managers must move far beyond focussing on content and records management and instead ensure they are capturing, retaining and transferring knowledge to strategically manage human capital, organizational change, and enterprise transformation.

At this year’s Knowledge and Information Management for Oil and Gas conference, taking place April 28-29 in Aberdeen, you will learn how to use the tools you need to drive improved performance through case studies that focus on the most value-driven, cost-effective and practical strategies for managing one of your company’s most valuable assets: knowledge and information.

The controlled release of a pharmaceutical active can be a vital tool in ensuring the safety and efficacy of a new or existing treatment. Developing new methods of controlled release is important to prolong the duration of action, can help to minimise adverse reactions and maximise efficacy as well as being an effective way of increasing a drug`s lifespan.

SMi`s 7th Controlled Release conference will provide you with the latest updates in this area, including controlled release development strategies, practical issues in developing controlled release therapeutics and information on the latest advances in delivery methods.

Key topics to be addressed at the conference include:

• The application of advanced science & technology to develop controlled release dosage forms
• Controlled Release - the role of intellectual property in maintaining and growing market share
• Controlled release in chronic diseases
• Overcoming the blood brain barrier
• Modified release multiparticulates 
• Hot melt extrusion: How to enhance dissolution rate by solid dispersions
• Developing novel inhaled controlled release therapeutics 

Sports Law & Business 2010 is THE best conference on the market focused on the key commercial and regulatory issues facing those advising on and involved in sport. 

In these times of financial downturn, governing bodies, clubs, teams and brands, must, more than ever, examine very carefully the way that they protect and leverage media rights and sponsorship in order to remain attractive in an increasingly competitive sports market. On the regulatory/governance side, sport simply must address the issues of cheating and drugs in order to maintain credibility.

Increasing Efficiency, Agility and Performance Through Continuous Improvement And Process Excellence

For Pharmaceutical, Biotech and Medical Devices companies, ensuring quality and economic efficiency are top of the agenda. The more streamlined your processes, from R&D to supply chain to manufacturing, the better the chances of beating your competitors. As Lean, Six Sigma and Continuous Improvement projects gather momentum in an ever competitive and changing market, successfully implementing process excellence initiatives has never been as important.

With the significant increase in M&A activity, merged organisations are now also having to accurately determine how to define, analyse, engineer and integrate process across multiple business units. These are neither quick nor easy challenges. But they are crucial to realising the projected benefits of mergers and to ensure the new company operates in a more efficient, cost-effective, process-driven way.

The aim of the conference is to challenge and inspire the water and environmental community by sharing knowledge and best practice, which is at the heart of meeting key global challenges.

In April 2010 CIWEM will hold a two-day Annual Conference that will address multidisciplinary issues across all areas of the global water and environment sector. There will be a mix of keynote speakers, offered papers, exhibitions and networking opportunities that will make this the key event for water and environment professionals.

The topics that are likely to be covered include:

• Flooding, urban drainage, surface water management, and the integration of water and flood management
  Sustainability.
• Climate change; mitigation and adaptation, food, energy and water security.
• Catchment, river basin and watershed management approaches, collaborative working.
• Water management – water resources, water quality, wastewater management, integrated water resource management.
• Environment sector policy, legislation and regulation, the political process.
• Investment and innovation; the opportunities and challenges of greening the economy.
• Societal impacts including arts and culture, well being, health, faith, and diversity on water and environmental issues

• A greater understanding of the evidence base for diagnosis of schizophrenia
• Comprehensive overviews of the current psychological and pharmacological treatment strategies including best practice in prescribing and monitoring medication and the role of CBT
• A raised awareness of the problems and solutions of managing psychosis during
• pregnancy
• Insights into the development of improved care pathways for co-occuring conditions
• An opportunity to share and exchange ideas with leading practitioners in the field

As global demand for power, heating and transportation fuels continues to grow and fossil fuel resources become scarcer and more expensive to extract biofuels play an ever greater role in meeting our energy needs.

Focusing on the latest technologies and processes Biomass to Liquids 2010 brings together experts from a wide range of disciplines. Technology developments, project updates, policy and regulation and the feedstock debate will all be addressed in this comprehensive two-day event.

As the nuclear renaissance moves full steam ahead with the UK giving the go-ahead for 10 new nuclear power stations,  it is ever more essential for investors, the government and utility companies to have a full awareness of the realistic financing options in this high risk and high capital industry.

SMi’s 3rd annual Financing Nuclear Power conference will bring together key experts and decision makers to share their experiences, offering practical advice and considering the realistic options for financing nuclear power in 2010.

Key topics include:

• The nuclear renaissance in the UK
• Financing new nuclear – challenges for the utility
• Decommissioning – successfully managing the costs
• Operational waste handling and storage - opportunities and risks
• Nuclear - an integral part of the future fuel mix
• From plan to production – insurance aspects
• Project management: from licensing to power generation
• Political lobbying for nuclear power
  

The worldwide generics industry has seen strong growth in recent times as the demand for affordable treatment has increased worldwide. In addition to this, numerous branded-drug patent expirations, the prospect of generic biotechnology drugs and a favourable regulatory environment is providing a huge opportunity for the sector to expand further.

Join us for SMi`s 13^th annual Generics, Super-Generics and Patent Strategies and discover the future of the generics market. Hear experts in the field discuss the latest patent strategies, regulatory updates and growth strategies that will be key to the future of the industry.

Key topics include:

• Examine the legal framework and litigation mechanics in both the EU and US 
• Latest legislative and regulatory updates in generics and biosimilars
• Identify key growth areas and methods to take advantage of these
• M&A activities and their implications
• New business models
• Emerging markets
• R&D in generics

In October 2008 the Government announced its intention to mandate a roll out of electricity and gas smart meters to all homes in Great Britain with the aim of completing the roll out by the end 2020. The Government published a ‘Consultation on Smart Metering for Electricity and Gas on 11 May 2009. This Consultation was aimed at confirming the shape and high-level requirements for the domestic roll-out. It also set out proposals to mandate a smart/advanced meter roll out for small and medium non-domestic sites.

Decisions set out in the Government Response Document provide the platform to launch the major programme of implementation work that will be needed to ensure that the Government’s goal of a full roll-out of smart meters by the end of 2020 is successfully achieved. To realise all the benefits fully, the roll-out of smart meters will need to be effectively designed, planned and co-ordinated at every stage. A major programme of work therefore needs to be taken forward under an Implementation Programme before the mass roll out of smart meters begins.

Join over 300 senior level industry experts during Smart Metering UK & Ireland 2010 and discuss the way forward in Europe’s largest smart metering roll-out!

During the period 2008-2013, the most important development in influenza vaccines, will be the diversification of influenza manufacturing. New cell-based technologies will be used, and eventually replace, existing egg-based manufacturing methods. Many cell-culture vaccines are being developed under grants from the US government.

Key themes:
• An overview of cell culture technology: The latest developments on cell-culture based vaccine production
• Cell line selection and development
• Mammalian cell culture processes for large scale operation
• Glycan analysis in cell culture-based influenza vaccine production
• Influence of host cell line and virus strain on the glycosylation pattern of viral Haemagglutinin
• Bulk Production, microcarrier cultures and free-cell suspension cultures
• Downstream processing parameters for purification, filling, and packaging of the cell culture based vaccines
• Flow cytometric monitoring of influenza virus infection
• Validation of cell culture based processes & qualification of associated equipment and facility
• Analysing ventures of global vaccines manufacturers in the developing world
• Regulatory issues associated with the development of cell-based influenza vaccine

SMi’s Retail Cards and Payments Conference will shine a spotlight on the market and provide a comprehensive analysis on all forms of retail payments from loyalty schemes and gift cards to vouchers and open-loop prepaid cards. Discover how they interact, the impact of new technology and most importantly; what the consumer really wants from its retailers.   

With an exceptional line up of speakers covering all of the most important issues, this is an unmissable opportunity to learn and network with the key personnel in the Retail Cards and Payments market. Book now to avoid missing out. 

For example

• Cervical cancer vaccine
• HPV in cervical screening
• The impact of HPV vaccines on cervical cancer screening programmes
• The changing role of the cytologist in diagnostic medicine
• Cell blocks - the interface between cytology and histopathology
• Molecular Pathology on cytology samples
• Is there a continuing role for Cytology in Breast Cancer Screening in the future

With the high costs of development for a new drug, no company can afford to further increase costs through inefficiencies in the clinical trial supply chain.  As an attempt is made to reduce expenses through conducting clinical trials in the emerging markets of Asia, India, South America and Eastern Europe there is an increasing need to ensure that your logistics procedures are as efficient and cost effective as possible.

SMi`s 4th annual Clinical Trial Logistics conference will address your concerns and provide you with the tools to safely and efficiently resolve your clinical trials logistical challenges on a global scale. This conference will also analyse the latest developments in labelling, packaging, inventory management, security, forecasting, partnering and outsourcing.

In recent years there has been an explosive growth in biological data which has to be managed and stored for various purposes. Bioinformatics plays a vital role in developing new tools for managing and analysing the data. The bioinformatics market is driven by the need of pharmaceutical and biotechnology companies to increase the efficiency of their drug-discovery and development efforts. The focus is now on target validation for translating genomic information into knowledge for developing therapeutics, proteomics and the changing trends in the drug discovery procedures.

Key Benefits:
• Examine DNA and RNA structure, function and sequence analysis
• Assess the challenges of data integration
• Evaluate the advantages of proteomic analysis to the drug industry
• Analyse the future regulatory environment
• Receive an update on the global informatics software market
• Gain an insight into the bioinformatics application in drug discovery
• Be part of a unique networking opportunity

Looking for a specialist forum for transport planning and optimisation professionals? Fed up with searching for relevant contacts and information at general trade shows? Then join the professionals at EMEA`s only specialist mobile transport event.

TNMO brings together over 200 senior professionals in your industry. It`s a unique forum at which you can:

• meet your peers from other mobile operators` transport departments
• find out how other operators are adapting their transport infrastructure to meet changing commercial and customer requirements
• compare the different evolution options offered by full solution and specialist vendors
• benchmarking your evolution plans with those of industry experts and your peers

SMX Advanced is the only search marketing conference designed exclusively for experienced internet marketers. Sessions are fast-paced, Q&A-packed, frequently controversial, always informative…and don’t stop to cover the basics. Fluent in search engine marketing? Come to SMX Advanced and engage with others who speak your native language.

Be a leader among the leaders in search marketing by attending. Influencing industry developments is an essential mission of SMX Advanced, which connects search marketers, decision makers from the search engines, and other key industry stakeholders. You’ll participate in conversations orchestrated to debate thorny issues and move the industry forward.

And there will be plenty of learning and sharing. The most accomplished search marketers in the world will present cutting edge tips for driving traffic and increasing conversions from paid search advertising, SEO, social media marketing, search analytics and more.

Convenience is an SMX Advanced hallmark:

• Need to stay connected? Our session rooms have Wifi. For free. For everyone.
• Need to plan your time? Use our SMX Connect social networking tool to meet others pre-show, develop your custom itinerary and reserve your place at birds-of-a-feather lunches.
• And don’t worry about finding something tasty and nourishing to eat. Breakfast, hot lunches, snacks and beverages are all included.

Finally, SMX Advanced is intentionally intimate, so you’ll be certain to meet the people you want to meet. This conference sold out in good times and bad each of the three years since it started in 2007. We could relocate and sell more tickets, but the ingredients — the content, networking, and energy — are too precisely formulated to change.

Whether you are developing a brand new process or optimizing an existing synthetic route, the aims are always the same:

• Achieving greater process efficiency, yield and throughput.
• Eliminating unsafe and non-green processes and materials.
• Decreasing the costs and number of steps involved.

Since the first conference in 1994, The Scale-Up of Chemical Processes has become the major international forum for the discussion of all these aspects of scale-up and more in the pharmaceutical, fine chemical and allied fields.

Key speakers will present case studies and examples of some of the pitfalls and problems they encountered and how they overcame them

Experts from over 40 top global and national brands will teach you how they are:

• Establishing a marketing metrics baseline
• Correlating offline and online measurements
• Connecting customer satisfaction data with customer behavior data
• Comparing online to other channels of acquisition and distribution
• Changing a corporate culture to embrace marketing experimentation
• Increase measurable value from your website, campaigns and communications
• Demystify the website audit process
• Discover web analytics basics at the Web Analytics Association (WAA) Base Camp - Introduction to Web Analytics and Search Analytics for Search Marketers
• We’ve been influencing customers through social media, but are we measuring results? Do we know what those measures are? Take your understanding of social media metrics to the next level
• Learn how best use of data, technology and processes improves the online customer experience and builds loyalty.
• Learn how companies are increasing marketing performance offline by listening and learning from customers online
• Discover how to create an analytics-based marketing and business culture
• Learn how to build a case for online marketing analytics, secure a budget and resources
• See hands-on demonstrations of the latest tools in action
• See case studies presented by senior web and ecommerce managers, marketers and analysts

The aim of this seminar is to provide an understanding of the nature of regulatory affairs in South Africa, Anglophone Africa as well as Francophone Africa.  The focus will be on all major markets as well as the smaller markets in general and will in particular, give advice on the timely compilation of the registration ‘packaging’.  All aspects of product and where appropriate, company registration will be discussed with reference to regulations and guidelines, in particular recent changes to these.  Both national and international trends will be referred to.

Who Should Attend

A comprehensive course designed for all personnel in the Pharmaceutical Industry new to or already dealing with Regulatory Affairs in Africa including South Africa.

Topics to be covered at this meeting:

• The Markets
• The Development of Drug Control
• Company and Product Registration
• Compilation of the Dossiers
• Regulatory Submission Strategy
• Agency Assessment
• Recent Developments in South Africa
• Interactive Workshop: Putting Learning into Practice
• Harmonisation and Co-operation Initiatives in Africa
• General Country Specific Discussion

C5`s Nuclear Interim Storage International Conference brings together a panel of experts comprising waste management organizations, utilities, government and regulatory bodies as well as technology providers to present you will an essential brief.

Leading authorities on nuclear waste management will share their knowledge and experiences to help you steer through 2010 and beyond, with specifically tailored case studies including:

• Creating a very strong interim storage agenda before the repository programme arrives
• Interim storage of spent nuclear fuel at Ignalina NPP
• Recent developments in technical guidance for the management of HLW’s
• Heading towards a global optimisation of waste management scenarios including waste packaging, transportation, interim storage and disposal
• Safety principles for the design of up-to-date storage facilities
• Measures to assure the disposability of radioactive waste following long term storage

It gives us great pleasure to invite you to `Breast Cancer Research 2010`, Breast Cancer Campaign`s third one-day scientific conference, on Tuesday 18 May 2010 at The Royal Society in the heart of London.

We look forward to a packed and varied programme that will encompass all aspects of breast cancer research, from prevention right through to treatment and beyond. Our specially invited keynote speakers will showcase their first class research along with excellent presentations selected from abstract submission in a single plenary session. Back by popular demand will also be an extensive selection of poster presentations; one of the many highlights of our 2008 conference.

The conference will bring together researchers from all over the world to celebrate current achievements in breast cancer research and provide an excellent opportunity to network with key researchers, share knowledge, exchange ideas and build collaborations.

As registration and abstract submission will be open to all individuals with an interest in breast cancer research and not restricted to Campaign-funded researchers, we hope you will be able to join us.

We look forward to welcoming you to London in May 2010.

Best wishes

Dr Suzanne Eccles
Chair

Professor Gareth Evans
Deputy Chair

Expert speakers will provide practical experiences, invaluable advice and strategic information on issues including:

• Communicating and clarifying your rewards package to ensure employees fully understand the value
• Empowering line managers to take ownership for the reward package
• Non-financial vs. financial rewards – making non-financial rewards valuable
• Financial education –increasing pension take-up and advising on financial savings in an economic downturn
• Adapting your rewards and benefits strategy in times of change: rewards acting as a support mechanism
• Measuring and evaluating the business benefits of your reward package: what is the impact on the bottom line?
• Identifying which factors keep employees working for you: how do you implement change in a package and convince employees they are not losing out?
• Retaining and engaging talent through rewards – how can reward support the succession plan?
• Achieving the right behavioural response: utilising reward to maximise both the internal and external brand to become the employer of choice
• Trends in executive reward
• Tailoring reward to the individual: offering flexible benefits and a greater choice
• Opportunities for staff through learning and development
• Effect of Corporate Social Responsibility on employee benefits
• Adjusting to a flexible working practice and supporting employees in times of personal crisis
• Fresh, simple and creative reward ideas

• Insights into effective sexual health promotion and STI prevention
• Expert opinions into developing accessible sexual health and contraceptive services
• Greater understanding of the diagnosis and clinical management of viral STIs including HIV
• Discussions about the management of STIs during pregnancy and in young people
• Further understanding of the psychological issues in sexual health
• Updates on advances in diagnosis and treatments of bacterial infections such as syphilis, NGU and gonorrhoea
• An opportunity to share and exchange ideas with leading practitioners in the field

eCTD is an interface for the pharmaceutical industry to agency transfer of regulatory information. In July 2009, the EMEA have made it clear that paper and other electronic formats will be an exception to the general e-CTD format recommended for any application. As it is not limited to the transfer of information it also applies to the creation, review, life cycle management and archival of electronic submission. Hence, drug manufacturers must consider new methodologies and adapt their organisation to change.

By attending this conference, you will:
• Discuss emerging trends in electronic submissions in the US & Europe, Filing CTDformatted 
• Identify challenges and benefits of transitioning to eCTD
• Hear the various methods of submitting electronic submissions to global health authorities
• Learn how to manage the lifecycle of an eCTD
• Understand if outsourcing is a rapid, cost-effective option for electronic submissions
• Recognise the vital role of good document management and best business practices in the overall process of preparing the eCTD
• Describe the role of eCTD standards and analysing their impact to the development/delivery process.

With more than 25 products in clinical use worldwide, including eight blockbusters, monoclonal antibodies have arrived as therapeutics. The global monoclonal antibodies market, worth $41bn in 2010, remains one of the most exciting and promising areas within the world pharmaceutical market today.

By attending this conference, you will gain key insights into the hottest topics and main drivers in mAb research and development today, including:
• Oligonucleotide, and new scaffold and next generation technologies
• The importance of isotyping in preclinical modelling
• New data from clinical trials for conjugated and unconjugated therapies
• Identifying and validating cell-surface antigens for antibody targeting
• Prospects for fragment monoclonal antibodies
• Overcoming immune reactions to improve clinical applications of antibody therapeutics
• Reducing inflammation and tissue damage in central nervous system diseases
• Market impact and post-marketing issues
• Prospects for inhibiting angiogenesis
• Perspectives on antibody process development including sharing IP, or implementing and licensing commercial process technologies
• Challenges facing implementation of anti-solid/liquid tumour therapies 

Following last year’s success, Pharma IQ is delighted to announce the dates for the 5th Annual Pharmaceutical & Biotech Patent Litigation Strategies Conference, taking place in London on 25th-26th May 2010, with pre-conference workshops on 24th May 2010

As more and more pharmaceutical products enter the market, the challenges associated with protecting a patent portfolio on an international scale are becoming increasingly complex. Furthermore, as the number of patents scheduled to expire hits record levels, there is mounting pressure to strengthen and protect both existing and new patents in order to secure the profit generated by patented products. Consequently, Pharmaceutical & Biotech Patent Litigation Strategies 2010 will provide you with an invaluable opportunity to learn the best approaches to navigate the ever evolving international IP landscape to ensure that your patent portfolio is protected and ultimately, that your product revenue is maximised.

“To help you know where you`re going”
The SS & O landscape is changing. And throughout 2010, as we map the path to economic recovery, it`s likely to change even more. And only Shared Services & Outsourcing Week delivers the vision of the industry`s future.

With cutting-edge panels from global SSO leaders and thought leadership from the biggest business leaders around the globe, you`ll be able to get to grips with the most critical front-of-mind challenges and take stock of the latest industry innovations needed to drive your SSO to the next level.

“And how you are going to get there”
Shared Services & Outsourcing Week provides a unique 360 degree view of world-class shared services and outsourcing models.

This year`s revamped agenda is now designed specifically to cover the complete spectrum of the SSO lifecycle. You can now select content from across 8 themed content tracks , tailored to different stages in your journey and build an agenda that fits your immediate delivery needs.

C5`s Energy Insurance conference will bring together the leading experts to provide you with the information you need to deal with risk management issues as well as valuable insights based on their vast collective experience with energy insurance.

Designed for Oil & Gas underwriters and other professionals in the upstream sector, this excellent event will cover the following areas and much more:

• What is the outlook for the energy insurance market for 2010 and beyond? – Panel discussion
• The latest developments in technology relating to oil & gas exploration and production
• Analysis of risks and coverage in the Gulf of Mexico – panel discussion
• Assessing risk with deep water coverage – how this impacts on risk assessment
• Business interruption – key issues
• Asset valuation, current strategies
• Control of well cover – understanding the risks from an insurers perspective
• New construction projects and their impact on energy insurance risk evaluation
• Energy insurance claims
• Decommissioning oil platforms

Following the huge success of the Customer Experience Exchange I’m delighted to announce the launch of the Customer Insight Exchange !

The Customer Insight Exchange offers Heads of Customer Feedback, Customer Insight, Customer Experience and Marketing the opportunity discuss strategies and solutions for extracting accurate and valuable data from multiple channels, applying data analytics and value modelling and creating insight that is actionable. The Customer Insight Exchange is Europe’s only event dedicated to Senior Level Executives responsible for customer insight and intelligence initiatives from global telecom, finance, retail, utility, travel and hospitality organisations.

One of the aims for this conference is to bring interested parties in organisations and government; researchers; policy makers; intervention specialists such as mediators, trainers, practitioners, therapists and counsellors together in a unified and synergistic format to enhance knowledge exchange and the dissemination of knowledge relating to workplace bullying and harassment.

The conference will enable researchers and practitioners to discuss and debate appropriate research and practicalities into matters affecting them at work to create new understanding; and to use that understanding to put in place positive strategies and interventions to create more meaningful, productive, and positive workplaces.

In today’s advertising and marketing world, there are new regulations to be met and new restrictions cropping up within all media channels. Local advertising campaigns need to comply with both local and national legislations. To complicate matters, once the campaign goes global, compensating for all the varying rules, regulations & cultural restrictions becomes increasingly difficult.

“Digital and tradition media are converging, but neither government nor industry can keep up.  How can we manage the myriad of conflicting standards and laws around the world?”
Bill Mordan , Senior Vice President and General Counsel, Reckitt Benckiser Plc

Following the enormous success of our 23rd Annual Advertising Law conference in the US, C5 is proud to present its forthcoming inaugural EU Advertising and Marketing Law Conference, the only event of its kind bringing you the latest, the best and the most innovative international brand case studies including:

• The EU Directive - an update on where the directive stands amongst Member States today and what its impact has been to date

• Green Marketing - how to advertise your product and get your message across in an eco-friendly marketplace

• Behavioural Marketing – determine how permissible it is to advertise and market to people based on searches, statistics, data and personal information

• Mobile Marketing, Video on Demand, Social Gaming - gain insight into current trends, on-going challenges and future developments

Plus:

International Panel Session on:

Sponsorship – hear from a panel of experts disclosing the difference between ambush marketing and free competition within their individual jurisdictions

Also:

Join the debate and interact with the leading experts discussing their views on:

• Unfair commercial practices
• Advertising to children
• Product placement

Effective forced degradation strategies assessing the stability in early phase of drug development is vital for the long term success of any drug. Analytical techniques are very sensitive to support very low levels of detection (LOD) and quantitation (LOQ). In recent years, analytical technologies have advanced so much that the detection of impurities at very low levels has become significantly less complex, though it still poses numerous challenges.

Learn, discuss and gain knowledge on:
• Forced degradation studies: groundwork and practical aspects
• Forced degradation concepts for small and big molecules
• Drug degradation chemistry within drug discovery
• Bioassays for assessing degradation
• Monitoring and evaluation of single amino acid modifications of therapeutic monoclonal antibodies
• Pre-formulation of proteins by high-throughput techniques
• Rapid and robust excipient selection during formulation development
• Comparing two different excipient screening approaches for the same drug
• Integrated approach to detect and quantify genotoxic impurities in APIs
• Quality by Design (QbD) application to GTI control strategy
• In silico Prediction of forced degradation
• Regulatory perspectives on drug degradation and stress testing

EAACI congresses now attract more abstracts and free communications than any other allergy congress worldwide, so we will make a special effort to ensure that everyone who presents new work at EAACI will get the opportunity both to present their work and to take part in discussions with colleagues and experts in their respective fields.

SMi ran its first conference on pain therapeutics in 2001, and has run a highly successful conference on this topic every year since.  In 2010, our industry-leading Pain Therapeutics conference returns for its tenth year, and will build on the knowledge-base and reputation that SMi has in this area to deliver the most interesting and informative conference yet.

Taking place in London, UK, this conference will look at a wide range of issues withing the pain therapeutics arena.  It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of biomarkers and the cannabinoid approach.

Questions examined during the conference will include: Do cannabinoid medicines have a place in our pain arsenal?  How do regulatory authorities treat emerging clinical development biomarkers.  What are the latest targets being researched?  How do we treat associated conditions for chronic pain?    How effective is translational research for pain measurement?  Attend this event to discover the latest success stories in researching and marketing pain therapeutics. 

Now in its 10th year, the SMi International Software Radio conference will once again give you the opportunity to review the latest programme updates, national capabilities, operational feedback and technological developments in the field of software defined radio.

Attend and meet with key national decision makers, who will update you on their national SDR programmes. What are the French, Spanish and Italian plans and how are they progressing with research and development? Furthermore, once again hear an update on NATO SDR and the NATO framework.

International Software Radio 2010 will also give you the opportunity to discuss the evolution of SDR with the people that matter. Assess the future and evolution of cognitive radio and learn how your organisation can take advantage of and develop this technology.

Mission planning for diverse and complex air operations remains a key challenge in order to maintain operational effectiveness. The modern aviator has always required efficient ground based mission planning in place; however, they increasingly need effective onboard tactical decision tools in order to deal with an unfolding situation and enjoy the full operational picture.

Assessing a wide range of military, commercial and humanitarian operations, Air Mission Planning will allow you to analyse the latest operations and experiences in delivering strategic, tactical and operational mission planning for air operations. With a range of presentations, take the opportunity to learn both national MOD and NATO perspectives and requirements.

Network with a senior line up of speakers and ensure that your organisation is at the forefront of providing fully interoperable mission planning systems and support to air operations.

Due to the continuous increase in the number of insoluble developmental drug molecules and growing regulatory scrutiny over pharmaceutical solids, the amorphous pharmaceutical materials have gained importance in the last few years. With the help of interactive discussions, leading presentations, participants will gain a comprehensive outlook of the current market trends, and discover the latest technological developments.

Reasons to register today:
• Understand the use of isothermal calorimetry to characterise stability of amorphous pharmaceuticals
• Implement the latest technological developments
• Discuss the best approaches to control and stabilise amorphous drug forms
• Examine the quantification of amorphous content
• Gain a clearer insight on amorphous food materials
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies

Biogas is heading towards establishing itself as one of the most forward looking forms of renewable energy in the coming years.

SMi’s inaugural Biogas 2010 will bring together leading industry experts, regulators, financiers and technology providers from all across Europe to help you understand and benefit from the underlying opportunities of Biogas development, especially in the UK. 

Make sure you attend this event and walk away with all the essential knowledge needed to maximise the potential, profitability and sustainability of your business.

The need for effective Enterprise Architecture has never been greater. As well as providing an overall framework for managing business and IT change, it helps to inform decisions on critical issues such as cost reduction, process improvement, mergers and acquisitions, and new ways of doing business.

At a time when business turbulence and technology diversity are both increasing, Enterprise Architects must make pragmatic decisions about how and where to direct their efforts. They must also evolve their approaches to reflect new business and IT delivery models.

The European Enterprise Architecture Conference attracts a wide range of experienced speakers and delegates from round the world and provides a unique opportunity to discover the approaches that work most effectively.

• Choose from 7 pre-conference seminars and 4 conference tracks.
• Explore what it takes to be a responsive business with agile processes, systems and technologies
• Evaluate what works best in different business environments, and what doesn`t, through practical case studies and examples from Global 2000 companies and major public services
• Gain renewed inspiration and fresh insights into the latest EA thinking and innovations.
• Share ideas and experiences through networking with others in similar situations
• All levels of experience catered for

According to the European Wind Energy Association (EWEA), O&M costs have dominated the economics of grid connected wind turbines in recent years; however O&M has oftentimes been neglected. The rapid development of this renewable energy industry means there has never been a more important time to safeguard wind farm assets and build on innovative O&M strategies in order to increase turbine reliability and in turn profits. Tough decisions need to be made quickly in this proactive industry to solve the challenges of offshore O&M, health and safety hazards, obsolescence of components and implementing new technologies.

Don’t let the important questions go unanswered such as:

• Should we implement condition based monitoring and if so, which one?
• How do we improve our accessibility to offshore wind farms?
• How do operators and manufacturers maintain strong lasting relationships?
• What new technologies should we be put into operation to increase efficiency?
• What are the important health and safety guidelines?
• How do we optimise our O&M strategies with our current wind farm portfolio?

Accurate and timely support of ground forces in Afghanistan has never been so important. Integrated and coordinated close air support plays a crucial role for protecting troops and saving lives. As the threat evolves so does the CAS mission. 

SMi’s Urban Close Air Support is well timed to provide you with the most up-to-date case studies from CAS operations in Afghanistan. Assess the lessons learned from missions and explore the latest requirements for FAC/JTAC simulation.

Welcome to Global MilSatCom 2010, Europe`s leading event for military satellite communications professionals.

Now in its 12th year, this event is your chance to network with an unparalelled line up of international decision makers in the SatCom arena. With delegate and exhibition places sold out once again in 2009, ensure that you book early and guarantee your place alongside 300 industry colleagues at the SatCom event of the year.

Over the years, Global MilSatCom has led the way in offering a diverse range of international military speakers. Meet with and learn from the key European and NATO players and also take the opportunity to learn from an array of other significant global SatCom leaders. From Australia, South Africa, Japan, USA, UAE and Canada, this event is a unique opportunity to meet an international array of SatCom decision makers.

Bubble London`s philosophy is to bring a new generation of kids trade show to the marketplace. Each event is carefully conceived as a focused trade show in a wonderful space, where retailers can meet exhibitors from every aspect of the kid`s world: clothing to toys, shoes, accessories and more.

Bubble London runs twice yearly in January and June in sync with the European calendar, and is the only standalone children`s trade event in the UK. It has grown from 60 exhibitors at its launch to over 190 carefully selected brands last season. Throughout this growth, the intimate atmosphere, the attention to detail and the human dimension of the shows have never been compromised. Bubble has become an international reference on the trade show circuit, a must-visit event for anyone with a keen eye on the fast changing and very exciting children`s market.

Trade only.

The global market for ophthalmic pharmaceuticals is a profitable and prestigious segment, set to reach total sales of $32.36bn by 2025 (IMS Health). Glaucoma and retinopathies remain the largest and fastest-growing therapeutic categories, and significant unmet needs. Neuroprotection is now the recognised Holy Grail for glaucoma, along with new technologies to boost patient compliance. For retinopathies, inhibiting geographic atrophy, oedema and neovascularisation remain significant challenges. For both, improved screening methods are driving clinical end-point validation.

Bringing you the latest in basic, pre-clinical, translational and clinical research, we showcase the latest in a field rich in opportunities. Updates from outstanding speakers cover:
• Full market analysis including prospects for pipeline therapies 
• New insights into retinal ganglion cell pathology, degeneration and apoptosis
• Innovative in vivo techniques to increase the spatial resolution of retinal imaging for the optic nerve and retina
• Increasing the effectiveness of neuroprotective agents beyond monotherapy
• Defining and validating clinical measures of neuroprotection
• Sustained release intraocular devices to boost patient compliance
• Gene, encapsulated-cell and cell replacement therapies for retinopathies
• Developments in anti VEGF treatments for wet AMD
• RNAi therapeutics for wet AMD and diabetic macular oedema
• Antibody therapies for age-related macular degeneration and diabetic retinopathy

The energy industry is undergoing some active transformations in the current marketplace. You as decision makers need to fully understand the opportunities & complexities arising out of these changes and protect yourself against any commercial, legal or operational risks.

SMi’s 5th annual Energy Risk Management conference will bring together renowned experts to debate on most prominent issues in the industry. The event will provide you the unique opportunity to address concerns and find solutions needed to succeed in these turbulent times.

With the uptake of contactless payment increasing exponentially it is fast becoming the payment method of choice. Simplicity and efficiency have moved contactless payment from the sidelines to a ubiquitous payment mechanism. SMi’s 8^th Annual Contactless Cards and Payments conference will shine a spotlight on the market and offer new insights into this rapidly advancing technology.

While enforcement of the US Foreign Corrupt Practices Act still grabs headlines and remains a critical standard by which to develop anti-corruption compliance programs, Europe has also seized the enforcement mantle. Recent cases such as Siemens, Balfour Beatty, Aon Ltd. and Halliburton all prove the incredible financial and reputational costs of non-compliance.

Now in its 6th successful year, this European Forum on Anti-Corruption Compliance and Enforcement will assemble a leading faculty of experienced in-house and private practice lawyers, compliance executives and government officials who will provide the latest insights to facilitate compliance with anti-corruption laws and mitigate damage should a violation ever happen.

Protein biotherapeutics have gone from a seldom used subset of treatments to a multi-billion dollar global industry. With the ever-expanding protein therapeutic market, SMi`s 6^th annual Global Protein Summit is well timed to investigate the latest developments in protein therapeutics, cell culture expression and immunogenicity.

The conference will explore the next generation of protein therapeutics, how they are being developed and reassess the technology, discovery and delivery trends. Also covered will be expression optimisation, case studies looking at successful drugs along with immunogenic considerations and safety assessment.

Reassess the latest therapeutics, developments, technologies, and methods that work in an interactive, networking friendly environment with major players from the biotech industry.

This meeting will feature talks from experts who will address:

• Optimisation of pre-formulation approaches, expression and glycosylation
• Next generation nanobodies
• Generating therapeutic antibodies to multi-transmembrane receptors
• Case studies in successful innovative biotherapeutics
• In silico methods to reduce development risks
• Recognising and combating immunogenicity
• Regulatory perspectives

Established among in-house and private practitioners alike as the market leading event, since 2001, thousands of life sciences patent professionals have made C5`s Pharma Patent Lifecycles Extension conferences their source of information for the most up-to-date legal developments surrounding patent lifecycle extension and management.

Extending the a product’s patent lifecycle has become increasingly important in the pharmaceutical industry. High R&D costs and the lengthy product testing times that are required before products can enter the market make it particularly important for companies to be able to extend their product exclusivity.

Maximising protection and value from extending the life of a patent has become more and more complex as patent, competition and regulatory law continually changes. Ground-breaking case law, legislative developments and evolving regulation mean that the rules of the game for effective patent lifecycle management and extension are constantly changing.

In this fast changing high stakes industry it is imperative to have an up-to-the-minute in-depth understanding of the decisions of the European and US courts and the very latest practices in Europe and the United States, including with the European Competion Commision.

In response to this, C5 has specifically designed its Pharma Patent Lifecycle Extension Conference to provide you with a sophisticated and comprehensive understanding of the issues you face today and offers you practical solutions. It will tell you everything you need to know from initial patent filing to obtaining regulatory data exclusivity. The will bring you up to date with the latest legal developments and offers the best practical solutions to your patent lifecycle management.

The 9th C5 Conference on Pharma Patent Lifecycle Extension brings together a panel of experts comprising regulators, leading patent practitioners and senior lawyers who will provide you with practical knowledge and strategic advice on:

• The Impact of Regulatory Data Protection on Lifecycle Management
• Recent Trends and Developments in Supplementary Protection Certificates and Paediatric Extensions
• The Latest Status of the European Competition Commision and the Dawn Raids
• Using Second Medical Use Claims to Extend Patent Lifecycles
• Collaboration to Extend Lifecycle
• How to Optimise Your Product`s Lifecycle Through Successful Global Patent Lifecycle Management
• Industry Case Study and Break Out Session: Insight into Pfizer`s European Lipitor Litigation

The current pressure on businesses to cut costs and improve revenues is likely to foster increased corruption risk-taking. Many European governments have strongly seized the enforcement mantle. The UK Bribery Bill which will come into force in 2010 has proved this point. The Bill will make it illegal to bribe a foreign official to obtain or retain business. If businesses fail to prevent a bribe being paid by their employees or by other firms on their behalf, they will face prosecution. The new corporate offence means that unlimited fines may be imposed on companies found guilty and individuals who make illegal and improper payments to secure business may face fines and imprisonment of up to ten years. Organisations which have not reviewed their risk profile are increasingly exposed. Recent cases of fraud underscore the importance of due diligence robust systems of control to detect and prevent fraudulent activities and that companies need to implement. 

C5’s Forum on Anti-Corruption, London Edition is THE annual event that continues to bring together key industry leaders and government representatives in order to discuss the critical issues and best practices for companies to improve their anti-corruption and anti-fraud policies in this ever changing landscape.

Share your knowledge and expertise with your industry peers and colleagues. Gain greater industry recognition as you join our group of business leaders who have helped to shape some of our most important industry conferences. This is an outstanding career, business networking and information sharing opportunity.

The 2010 meeting will offer a high quality scientific programme of interest to both clinical and basic scientists. Based on the steady participation this meeting has attracted over the last few years, we are expecting some 3,000 delegates to attend.

Highlights will include the following:

• An exciting programme of invited speaker lectures featuring some of the world`s leading experts in the field
• Meet the professor sessions
• Joint ECTS-ASBMR debate
• Well-attended poster sessions with dedicated poster viewing time
• A busy exhibition area with lunch included in the delegate fee
• Company-supported satellite symposia highlighting some of the latest developments and research
• Allied health professionals session
• ECTS training course on clinical trials

This is SMi`s fifth conference on the subject of RNAi, siRNA and miRNA.  It will build on the success of the past four years, and brings together the leading experts in industry and academia to explore the cutting edge of new therapeutics being researched and brought to the marketplace.

Taking place in London, UK, this conference will look at a wide range of issues within the RNAi arena.  It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of delivery, target identification  and IP issues.

Questions examined during the conference will include: What are the best delivery methods for siRNA and RNA-based therapeutics?  How do you carry out gene silencing?  What is the best method to use an siRNA library for target identification?  How is cell stress related to decreased RNAi?  What are the patent issues for oligonucleotides?  How do miRNAs regulate gene expression?

The International Conference on Information Society (i-Society 2010) is Technically Co-Sponsored by IEEE UK/RI Computer Chapter. The i-Society 2010 is a global knowledge-enriched collaborative effort that has its roots from both academia and industry. The conference covers a wide spectrum of topics that relate to information society, which includes technical and non-technical research areas.

The mission of i-Society 2010 conference is to provide opportunities for collaboration of professionals and researchers to share existing and generate new knowledge in the field of information society. The conference encapsulates the concept of interdisciplinary science that studies the societal and technological dimensions of knowledge evolution in digital society. The i-Society bridges the gap between academia and industry with regards to research collaboration and awareness of current development in secure information management in the digital society.

With the importance of securing reliable energy sources the value attached to gas storage facilities will continue to rise. The focus of this conference will allow you to gain an understanding of the key developments in gas storage in areas such as: engineering, commercial prospects, development of infrastructure, regulation and the energy supply outlook.

Join experts at the 4th annual Gas Storage conference for interactive debate and in-depth discussion of the most pressing issues facing the industry.

Key topics to be addressed:

• The market dynamics and future of gas storage
• Challenges and benefits of UGS
• Developing storage potential through facilities improvement
• Regulatory considerations including regional approaches
• Storage investment in the current economic climate
• Financing the security of supply and funding long term gas shortage
• Market mechanisms and trading perspective
• The LNG angle

Show Highlights:

• 2 day conference and exhibition
• Co-located with CloudCamp London - Free-to-Attend unconference - click here to register
• Co-located with the Green Enterprise World Forum - 1 day conference on Green IT
• Free to attend exhibition with seminar and scenario theatre - click here to register
• Hear from leading case studies on how they have integrated Cloud Computing and Enterprise 2.0 into their working practices
• Learn from the key players offering cloud and enterprise 2.0 services
• All exhibition passes also include access to the Keynote presentation on each day
• Benefit from our pre-show online meeting planner
• Network in our combined exhibition and catering area
• Evening networking party for all attendees

In-House Counsel, Law Firms and Outsourcing Providers will provide case studies, strategies and real-world solutions relating to the following:

• LPO Business Models
• LPO Strategy: Achieving business-wide buy-in
• Questions to ask when selecting an LPO Service Provider
• Structuring and Negotiating the Outsourcing Agreement
• Ethical and other considerations when considering LPO
• Preserving Quality of Service in LPO

Purpose: To provide the physician with a working knowledge of clinically relevant and up-to-date topics using a combined lecture and case study approach. This review will provide a practical overview of commonly encountered problems in clinical cardiology, focusing on prevention, diagnosis, and treatment. For each topic, cardiology essentials will be reviewed and illustrative cases explored and discussed. Participants will be invited to share their clinical experiences, concerns, and insights.

C5`s Nuclear Decommissioning conference, aims to deal with the legal complexities & challenges faced by a cross-section of the industry. The legal & regulatory hurdles to the decommissioning strategy are more developed than new build, but no less complex.

Following the overwhelming success of C5’s inaugural Nuclear Decommissioning Conference in July 2009, we are pleased to announce that the UK and Europe’s leading Decommissioning experts will be meeting in Manchester to discuss topical issues such as:

• The NDA’s future strategy – what funding is actually in place?
• How reductions in Government public spending will affect Decommissioning projects
• How Tier 1’s and operators are tying-up current decommissioning projects with New Build opportunities
• The complexity in setting up and operating decommissioning funds for new build projects
• The impact of the European safety directive on UK Decommissioning projects
• How changes in legislation will affect liability for supply chain members

The WCE 2010 is composed of the following 15 conferences (all will be held at the same location and date):

ICAEM`10  - The 2010 International Conference of Applied and Engineering Mathematics

ICCIIS`10  - The 2010 International Conference of Computational Intelligence and Intelligent Systems

ICCSDE`10 - The 2010 International Conference of Computational Statistics and Data Engineering

ICCSE`10   - The 2010 International Conference of Computer Science and Engineering

ICDMKE`10 - The 2010 International Conference of Data Mining and Knowledge Engineering

ICEEE`10   - The 2010 International Conference of Electrical and Electronics Engineering

ICFE`10     - The 2010 International Conference of Financial Engineering

ICIE`10     - The 2010 International Conference of Information Engineering

ICISIE`10  - The 2010 International Conference of Information Security and Internet Engineering

ICME`10    - The 2010 International Conference of Mechanical Engineering

ICMEEM`10- The 2010 International Conference of Manufacturing Engineering and Engineering Management

ICPDC`10  - The 2010 International Conference of Parallel and Distributed Computing

ICSBB`10  - The 2010 International Conference of Systems Biology and Bioengineering

ICSIE`10   - The 2010 International Conference of Signal and Image Engineering

ICWN`10   - The 2010 International Conference of Wireless Networks  

• The conference will provide a wide range of CPD opportunities for teachers including,
• Updating key areas in psychology
• Sharing good practice with colleagues
• Seminars with examiners from the
• Awarding Bodies Displays and demonstrations from educational publishers
• Using technology in teaching